Skip to search formSkip to main contentSkip to account menu

ISIS104838

Known as: ISIS-104838 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Phosphorothioate Oligonucleotides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Technology evaluation: ISIS-104838, OraSense.
  • P. Kennewell
  • Current opinion in molecular therapeutics (Print)
  • 2003
  • Corpus ID: 40141364
OraSense Ltd (a joint venture between Isis Pharmaceuticals Inc and Elan Corp) is developing ISIS-104838, an antisense… 
2003
2003
Gateways to clinical trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)